Evading antimicrobial resistance using boron-containing therapeutics

Future Med Chem. 2021 Feb;13(3):229-232. doi: 10.4155/fmc-2020-0161. Epub 2020 Dec 4.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / antagonists & inhibitors
  • Bacterial Proteins / metabolism
  • Boron / chemistry*
  • Drug Resistance, Bacterial / drug effects
  • Leucine-tRNA Ligase / antagonists & inhibitors
  • Leucine-tRNA Ligase / metabolism
  • Mycobacterium tuberculosis / metabolism
  • Oxidoreductases / antagonists & inhibitors
  • Oxidoreductases / metabolism
  • beta-Lactamases / chemistry
  • beta-Lactamases / metabolism

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Oxidoreductases
  • InhA protein, Mycobacterium
  • beta-Lactamases
  • Leucine-tRNA Ligase
  • Boron